Incyte Corp financial data

Symbol
INCY on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
1801 Augustine Cut Off, Wilmington, DE
State of incorporation
DE
Fiscal year end
December 31
Former names
INCYTE INC (to 3/28/2003), INCYTE GENOMICS INC (to 2/25/2003), INCYTE PHARMACEUTICALS INC (to 4/18/2000)
Latest financial report
10-Q - Q3 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 272 % -28.5%
Quick Ratio 5.44 % +36.1%
Debt-to-equity 40.8 % +31.8%
Return On Equity 0.78 % -91.5%
Return On Assets 0.55 % -92.1%
Operating Margin 21.6 % +43.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 193M shares -14%
Common Stock, Shares, Outstanding 193M shares -14%
Entity Public Float 11.7B USD -17.6%
Common Stock, Value, Issued 192K USD -14.3%
Weighted Average Number of Shares Outstanding, Basic 193M shares -14%
Weighted Average Number of Shares Outstanding, Diluted 196M shares -13.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.32B USD +22.1%
Revenue from Contract with Customer, Excluding Assessed Tax 4.08B USD +12.9%
Cost of Revenue 293M USD +20%
Research and Development Expense 2.59B USD +53.5%
Costs and Expenses 4.13B USD +32.9%
Operating Income (Loss) -52.9M USD -111%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 274M USD -57.5%
Income Tax Expense (Benefit) 241M USD +10.3%
Net Income (Loss) Attributable to Parent 32.5M USD -92.4%
Earnings Per Share, Basic 0.17 USD/shares -91%
Earnings Per Share, Diluted 0.14 USD/shares -92.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.3B USD -59.6%
Inventory, Net 70.4M USD +23.2%
Assets, Current 2.81B USD -36.2%
Deferred Income Tax Assets, Net 762M USD +35.1%
Property, Plant and Equipment, Net 773M USD +5.46%
Goodwill 156M USD 0%
Other Assets, Noncurrent 40.4M USD -50.1%
Assets 5.01B USD -21.5%
Accounts Payable, Current 179M USD +28.2%
Employee-related Liabilities, Current 151M USD +20.8%
Accrued Liabilities, Current 1.13B USD +37.5%
Liabilities, Current 1.5B USD +33.5%
Operating Lease, Liability, Noncurrent 14.3M USD +1.24%
Other Liabilities, Noncurrent 145M USD +8.72%
Liabilities 1.84B USD +26.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 15.7M USD -31.6%
Retained Earnings (Accumulated Deficit) -1.27B USD -3031%
Stockholders' Equity Attributable to Parent 3.17B USD -35.7%
Liabilities and Equity 5.01B USD -21.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 219M USD
Net Cash Provided by (Used in) Financing Activities -12.4M USD -410%
Net Cash Provided by (Used in) Investing Activities -73.1M USD -156%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 193M shares -14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 133M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.31B USD -59.6%
Deferred Tax Assets, Valuation Allowance 2.1B USD +344%
Deferred Tax Assets, Gross 2.77B USD +185%
Operating Lease, Liability 20M USD -10.5%
Payments to Acquire Property, Plant, and Equipment 48.7M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 25.2M USD -94.7%
Lessee, Operating Lease, Liability, to be Paid 22.6M USD -10.6%
Property, Plant and Equipment, Gross 1.09B USD +10.4%
Operating Lease, Liability, Current 4.35M USD -29.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.41M USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.51M USD -28.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.67M USD -11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.89M USD +41.7%
Deferred Tax Assets, Operating Loss Carryforwards 326M USD +79.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 69.1M USD -5.33%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.9M USD +90.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 21.9M USD +14.2%
Deferred Tax Assets, Net of Valuation Allowance 672M USD +34.3%
Share-based Payment Arrangement, Expense 254M USD +21.9%
Interest Expense 2.51M USD +2.32%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%